Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 261-268

  Endo, Satoshi ^a,b   Matsunaga, Toshiyuki ^a   Ohta, Chisato ^a   Soda, Midori ^a   Kanamori, Ayano ^a   Kitade, Yukio ^b   Ohno, Satoshi ^b   Tajima, Kazuo ^c   El Kabbani, Ossama ^d   Hara, Akira ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

^d MONASH UNIVERSITY   (Australia)

Author keywords

AKR1C15; AKR1C3; Alcohol dehydrogenase; Aldehyde dehydrogenase; Farnesol; Geranylgeraniol

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDO KETO REDUCTASE; ALDO KETO STEROID REDUCTASE 1B10; ALDO KETO STEROID REDUCTASE 1C15; ALDO KETO STEROID REDUCTASE 1C3; BETAMETHASONE; CARBOXYLIC ACID; FARNESOL; FLURBIPROFEN; GERANYLGERANIOL; INDOMETACIN; MECLOFENAMIC ACID; MEDROXYPROGESTERONE; MEFENAMIC ACID; STEROID REDUCTASE; TOLFENAMIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; CATALYSIS; CELL CULTURE; CELLULAR DISTRIBUTION; COLON; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; IC 50; LIVER; LUNG; MICROSOME; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STOMACH; TISSUE DISTRIBUTION; TISSUE METABOLISM;

ALDEHYDES; ANIMALS; CELL LINE; CYTOSOL; DITERPENES; FARNESOL; HUMANS; MICROSOMES; OXIDOREDUCTASES; RATS; TERPENES;

RATTUS;

EID: 79957566848     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.12.017     Document Type: Conference Paper

References (50)

1. J.L. Goldstein, M.S. Brown, Regulation of the mevalonate pathway, Nature 343 (1990) 425-430.
2. P.A. Edwards, J. Ericsson, Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway, Annu. Rev. Biochem. 68 (1999) 157-185. (Pubitemid 29449190)
3. M. Bifulco, Role of the isoprenoid pathway in ras transforming activity, cytoskeleton organization, cell proliferation and apoptosis, Life Sci. 77 (2005) 1740-1749.
4. V.S Bansal, S. Vaidya, Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes, Arch. Biochem. Biophys. 315 (1994) 393-399.
5. S.E. Ownby, R.J. Hohl, Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis, Lipids 38 (2003) 751-759.
6. J.B. Roullet, R.L. Spaetgens, T. Burlingame, Z.P. Feng, G.W. Zamponi, Modulation of neuronal voltage-gated calcium channels by farnesol, J. Biol. Chem. 274 (1999) 25439-25446.
7. T.A. Kocarek, N.A. Mercer-Haines, Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor, Mol. Pharmacol. 62 (2002) 1177-1186.
8. N. Takahashi, T. Kawada, T. Goto, T. Yamamoto, A. Taimatsu, N. Matsui, K. Kimura, M. Saito, M. Hosokawa, K. Miyashita, T. Fushiki, Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes, FEBS Lett. 514 (2002) 315-322. (Pubitemid 34273961)
9. B.M. Forman, B. Ruan, J. Chen, G.J. Schroepfer Jr., R.M. Evans, The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10588-10593.
10. T.J. Kotti, D.M. Ramirez, B.E. Pfeiffer, K.M. Huber, D.W. Russell, Brain cholesterol turnover required for geranylgeraniol production and learning in mice, Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3869-3874. (Pubitemid 43376647)
11. S.J. Fliesler G.J.Jr., Schroepfer metabolism of mevalonic acid in cell-free homogenates of bovine retinas. Formation of novel isoprenoid acids, J. Biol. Chem. 258 (1983) 15062-15070.
12. D. Gonzalez-Pacanowska, B. Arison, C.M. Havel, J.A. Watson, Isopentenoid synthesis in isolated embryonic Drosophila cells. Farnesol catabolism and - oxidation, J. Biol. Chem. 263 (1988) 1301-1306. (Pubitemid 18039931)
13. G.R. Waller, Dehydrogenation of trans-trans farnesol by horse liver alcohol dehydrogenase, Nature 207 (1965) 1389-1390.
14. W.M. Keung, Human liver alcohol dehydrogenases catalyze the oxidation of the intermediary alcohols of the shunt pathway of mevalonate metabolism, Biochem. Biophys. Res. Commun. 174 (1991) 701-707.
15. Y. Kodaira, K. Usui, I. Kon, H. Sagami, Formation of (R)-2,3- dihydrogeranylgeranoic acid from geranylgeraniol in rat thymocytes, J. Biochem. 132 (2002) 327-334. (Pubitemid 34947897)
16. Y. Shidoji, N. Nakamura, H. Moriwaki, Y. Muto, Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosis, Biochem. Biophys. Res. Commun. 230 (1997) 58-63. (Pubitemid 27210242)
17. X. Wang, J. Wu, Y. Shidoji, Y. Muto, N. Ohishi, K. Yagi, S. Ikegami, T. Shinki, N. Udagawa, T. Suda, Y. Ishimi, Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation, J. Bone Miner. Res. 17 (2002) 91-100.
18. Y. Kodaira, T. Kusumoto, T. Takahashi, Y. Matsumura, Y. Miyagi, K. Okamoto, Y. Shidoji, H. Sagami, Formation of lipid droplets induced by 2,3- dihydrogeranylgeranoic acid distinct from geranylgeranoic acid, Acta Biochim. Pol. 54 (2007) 777-782.
19. L. Zhang, W.R. Tschantz, P.J. Casey, Isolation and characterization of a prenylcysteine lyase from bovine brain, J. Biol. Chem. 272 (1997) 23354-23359.
20. J.Y. Lu, S.L. Hofmann, Thematic review series: lipid posttranslational modifications. Lysosomal metabolism of lipid-modified proteins, J. Lipid Res. 47 (2006) 1352-1357.
21. S. Endo, T. Matsunaga, K. Horie, K. Tajima, Y. Bunai, V. Carbone, O. El-Kabbani, A. Hara, Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues, Arch. Biochem. Biophys. 465 (2007) 136-147. (Pubitemid 47283988)
22. M.P. Doyle, M. Yan, Attempted synthesis of casbene by intramolecular cyclopropanation, ARKIVOC 2002 (2002) Part viii 180-185. (Pubitemid 38977528)
23. O. El-Kabbani, P.J. Scammells, J. Gosling, U. Dhagat, S. Endo, T. Matsunaga, M. Soda, A. Hara, Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20α-hydroxysteroid dehydrogenase (AKR1C1), J. Med. Chem. 52 (2009) 3259-3264.
24. S. Endo, T. Matsunaga, H. Mamiya, C. Ohta, M. Soda, Y. Kitade, K. Tajima, H.T. Zhao, O. El-Kabbani, A. Hara, Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids, Arch. Biochem. Biophys. 487 (2009) 1-9.
25. S. Ishikura, N. Usami, K. Kitahara, T. Isaji, K. Oda, J. Nakagawa, A. Hara, Enzymatic characteristics and subcellular distribution of a short-chain dehydrogenase/ reductase family protein, P26h, in hamster testis and epididymis, Biochemistry 40 (2001) 214-224.
26. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, second ed., Cold Spring Harbor Laboratory, New York, 1989.
27. M. Sanai, S. Endo, T. Matsunaga, S. Ishikura, K. Tajima, O. El-Kabbani, A. Hara, Rat NAD+-dependent 3α-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo - keto reductase family highly expressed in kidney cytosol, Arch. Biochem. Biophys. 464 (2007) 122-129. (Pubitemid 47088362)
28. T. Iino, M. Tabata, S. Takikawa, H. Sawada, H. Shintaku, S. Ishikura, A. Hara, Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo - keto reductase AKR1 family members, Arch. Biochem. Biophys. 416 (2003) 180-187. (Pubitemid 36957843)
29. K. Matsuura, A. Hara, Y. Deyashiki, H. Iwasa, T. Kume, S. Ishikura, H. Shiraishi, Y. Katagiri, Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes, Biochem. J. 336 (1998) 429-436. (Pubitemid 28564401)
30. H. Shiraishi, S. Ishikura, K. Matsuura, Y. Deyashiki, M. Ninomiya, S. Sakai, A. Hara, Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA, Biochem. J. 334 (1998) 399-405. (Pubitemid 28448583)
31. 2 11-ketoreductase activity, J. Biochem. 124 (1998) 940-946.
32. S. Ohno, M. Matsui, T. Yokogawa, M. Nakamura, T. Hosoya, T. Hiramatsu, M. Suzuki, N. Hayashi, K. Nishikawa, Site-selective post-translational modification of proteins using an unnatural amino acid, 3-azidotyrosine, J. Biochem. 141 (2007) 335-343. (Pubitemid 46770386)
33. T. Matsunaga, Y. Shinoda, Y. Inoue, S. Endo, O. El-Kabbani, A. Hara, Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal, Chem. Biol. Interact. 191 (2011) 364-370.
34. R. Lindahl, S. Evces, Rat liver aldehyde dehydrogenase. I. Isolation and characterization of four high Km normal liver isozymes, J. Biol. Chem. 259 (1984) 11986-11990.
35. T.L. Kelson, J.R. Secor McVoy, W.B. Rizzo, Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization, Biochim. Biophys. Acta 1335 (1997) 99-110. (Pubitemid 27174510)
36. D.Y. Mitchell, D.R. Petersen, Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase, Arch. Biochem. Biophys. 269 (1989) 11-17. (Pubitemid 19052284)
37. K. Miyauchi, R. Masaki, S. Taketani, A. Yamamoto, M. Akayama, Y. Tashiro, Molecular cloning, sequencing, and expression of cDNA for rat liver microsomal aldehyde dehydrogenase, J. Biol. Chem. 266 (1991) 19536-19542. (Pubitemid 21908263)
38. P. Julià, J. Farrés, X. Parés, Characterization of three isoenzymes of rat alcohol dehydrogenase. Tissue distribution and physical and enzymatic properties, Eur. J. Biochem. 162 (1987) 179-189.
39. 2-receptor antagonists as pharmacological inhibitors, of human class IV alcohol dehydrogenase, FEBS Lett. 426 (1998) 362-366.
40. M.D Boleda, N. Saubi, J. Farrés, X. Parés, Physiological substrates for rat alcohol dehydrogenase classes: aldehydes of lipid peroxidation, -hydroxyfatty acids, and retinoids, Arch. Biochem. Biophys. 307 (1993) 85-90.
41. A. Sunde, P.A. Rosness, K.B. Eik-Nes, Effects in vitro of medroxyprogesterone acetate on steroid metabolizing enzymes in the rat: selective inhibition of 3α-hydroxysteroid oxidoreductase activity, J. Steroid Biochem. 17 (1982) 197-203. (Pubitemid 12064469)
42. T.M. Penning, I. Mukharji, S. Barrows, P. Talalay, Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs, Biochem. J. 222 (1984) 601-611. (Pubitemid 14007827)
43. T.E. Smithgall, T.M. Penning, Indomethacin-sensitive 3α- hydroxysteroid dehydrogenase in rat tissues, Biochem. Pharmacol. 34 (1985) 831-835.
44. T. Matsunaga, S. Shintani, A. Hara, Multiplicity of mammalian reductases for xenobiotic carbonyl compounds, Drug Metab. Pharmacokinet. 21 (2006) 1-18.
45. D.R. Bauman, S.I. Rudnick, L.M. Szewczuk, Y. Jin, S. Gopishetty, T.M. Penning, Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo - keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes, Mol. Pharmacol. 67 (2005) 60-68.
46. S. Gobec, P. Brozic, T.L. Rizner, Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo - keto reductase AKR1C3: new lead compounds for the development of anticancer agents, Bioorg. Med. Chem. Lett. 15 (2005) 5170-5175. (Pubitemid 41463641)
47. S. Endo, T. Matsunaga, K. Kuwata, H.T. Zhao, O. El-Kabbani, Y. Kitade, A. Hara, Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10, Bioorg. Med. Chem. 18 (2010) 2485-2490.
48. S. Endo, T. Matsunaga, M. Soda, K. Tajima, H.T. Zhao, O. El-Kabbani, A. Hara, Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid, Biol. Pharm. Bull. 33 (2010) 886-890.
49. T.M. Penning, M.C. Byrns, Steroid hormone transforming aldo - keto reductases and cancer, Ann. N.Y. Acad. Sci. 1155 (2009) 33-42.
50. J. Liu, G. Wen, D. Cao, Aldo - keto reductase family 1 member B1 inhibitors: old drugs with new perspectives, Recent Pat. Anticancer Drug Discov. 4 (2009) 246-253.